Quarterly report pursuant to Section 13 or 15(d)

Note 6 - Inventory, Net

v3.23.2
Note 6 - Inventory, Net
6 Months Ended
Jun. 30, 2023
Notes to Financial Statements  
Inventory Disclosure [Text Block]

6.

Inventory, Net

 

The components of inventory, net as of June 30, 2023 and December 31, 2022 are as follows:

 

   

June 30,

2023

   

December 31,

2022

 

Materials

  $ 27,405     $ 27,405  

Work in process

    433,341       399,939  

Finished goods

    131,804       131,804  

Reserve for expiring finished goods

    (131,804

)

    (131,804

)

Total inventory, net

  $ 460,746     $ 427,344  

 

No finished goods inventory was allocated for use in clinical trials during the three-month or six-month periods ended June 30, 2023 and 2022.